{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-251090","form_type":"8-K","ticker":"AMGN","cik":"0000318154","company_name":"AMGEN INC","filed_at":"2023-10-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.629230+00:00","generated_at":"2026-06-10T04:20:32.072432+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Amgen's acquisition of Horizon Therapeutics sanctioned by Irish High Court","bullets":["Irish High Court sanctioned the scheme of arrangement on October 5, 2023, moving deal closer to completion.","Completion remains subject to delivery of the court order to the Registrar of Companies in Ireland.","Deal originally announced December 11, 2022, valued at ~$27.8B."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-251090","json":"https://secwatch.observer/filing/0001193125-23-251090.json","markdown":"https://secwatch.observer/filing/0001193125-23-251090.md","text":"https://secwatch.observer/filing/0001193125-23-251090.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/318154/000119312523251090/0001193125-23-251090-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/318154/000119312523251090/d533762d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T04:20:32.072432+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}